Vigabatrin for the Treatment of Cocaine Dependency

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

207

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

October 31, 2012

Study Completion Date

December 31, 2012

Conditions
Cocaine AddictionCocaine Dependence
Interventions
DRUG

Vigabatrin

Tablets

DRUG

Matching Placebo

Tablets

Trial Locations (13)

15213

Western Psychiatric Inst. and Clinic, Pittsburgh

21229

Mountain Manor Treatment Center @ Baltimore, Baltimore

29403

Medical University of South Carolina, Charleston

33136

University of Miami School of Medicine, Miami

60523

NeuroPsychiatric Research & Practice Assoc., Ltd., Oak Brook

75243

Pillar Clinical Research, LLC, Dallas

77054

University of Texas Health Science Center at Houston, Houston

80220

VA Medical Center, Denver

84148

George E Wahlen VA Medical Center, Salt Lake City

87102

Pacific Institute for Research and Evaluation, Albuquerque

90016

Matrix Institute on Addictions, Los Angeles

90502

Friends Research Institute, Torrance

02118

Boston University School of Medicine, Boston

Sponsors
All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

collaborator

VA Office of Research and Development

FED

lead

Catalyst Pharmaceuticals, Inc.

INDUSTRY

NCT01281202 - Vigabatrin for the Treatment of Cocaine Dependency | Biotech Hunter | Biotech Hunter